Murat Senturk

Dr. Murat Senturk


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2009 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
MSMurat Senturk
Murat Senturk
IGİlHami Gülçin
İlHami Gülçin
ADArif Daştan
Arif Daştan
ÖKÖ. İrFan Küfrevioğlu
Ö. İrFan Küfrevioğlu
Claudiu SupuranClaudiu Supuran
Claudiu Supuran

19 February 2011 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PDF file
MSMurat Senturk
Murat Senturk
Ilhami GulcinIlhami Gulcin
Ilhami Gulcin
ŞBŞükrü Beydemir
Şükrü Beydemir
ÖKÖ. İrfan Küfrevioğlu
Ö. İrfan Küfrevioğlu
Claudiu SupuranClaudiu Supuran
Claudiu Supuran

1 July 2011 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
SSSevim Beyza Öztürk Sarikaya
Sevim Beyza Öztürk Sarikaya
FTFevzi Topal
Fevzi Topal
MSMurat Senturk
Murat Senturk
IGİlHami Gülçin
İlHami Gülçin
CSClaudiu T. Supuran
Claudiu T. Supuran

1 October 2008 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
EBEsra Bayram
Esra Bayram
MSMurat Senturk
Murat Senturk
OKO. Irfan Kufrevioglu
O. Irfan Kufrevioglu
Claudiu SupuranClaudiu Supuran
Claudiu Supuran

25 October 2011 in Expert Opinion on Therapeutic Patents
Verified
Journal Article
Closed access
DEDeniz Ekinci
Deniz Ekinci
MSMurat Senturk
Murat Senturk
ÖKÖmer İrFan Küfrevioğlu
Ömer İrFan Küfrevioğlu
(2011). Salicylic acid derivatives: synthesis, features and usage as therapeutic tools. Expert Opinion on Therapeutic Patents: Vol. 21, No. 12, pp. 1831-1841. doi: 10.1517/13543776.2011.636354

14 December 2011 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
DEDerya Ekinci
Derya Ekinci
LKLutfi Karagoz
Lutfi Karagoz
DEDeniz Ekinci
Deniz Ekinci
MSMurat Senturk
Murat Senturk
Claudiu SupuranClaudiu Supuran
Claudiu Supuran
A series of flavonoids, such as quercetin, catechin, apigenin, luteolin, morin, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA). The compounds were tested against four α-CA isozymes purified from human and bovine (hCA I, hCA II, bCA III, hCA IV) tissues. The four isozymes showed quite diverse inhibition profiles with these compounds. The flavonoids inhibited hCA I with KI-s in the range of 2.2–12.8 μM, hCA II with KI-s in the range of 0.74–6.2 μM, bCA III with KI-s in the range of 2.2–21.3 μM, and hCA IV with inhibition constants in the range of 4.4–15.7, with an esterase assay using 4-nitrophenyl acetate as substrate. Some simple phenols/sulfonamides were also investigated as standard inhibitors. The flavonoids incorporate phenol moieties which inhibit these CAs through a diverse, not yet determined inhibition mechanism, compared to classic inhibitors such as the sulfonamide/sulfamate ones.